<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://articlefeeds.nasdaq.com/~d/styles/itemcontent.css"?><rss xmlns:a10="http://www.w3.org/2005/Atom" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
  <channel xmlns:nasdaq="http://nasdaq.com/reference/feeds/1.0/">
    <title>Latest Articles about IBB</title>
    <description />
    <language>EN-US</language>
    <lastBuildDate>Sat, 18 May 2013 10:32:05 -0400</lastBuildDate>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://articlefeeds.nasdaq.com/nasdaq/symbols?symbol=IBB" /><feedburner:info uri="nasdaq/symbols" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item xml:base="http://www.nasdaq.com/article/oil-pulling-back-gold-retesting-lows-what-8-key-charts-are-signaling-cm246390">
      <guid isPermaLink="false">246390</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fuxvGNFmxWw/oil-pulling-back-gold-retesting-lows-what-8-key-charts-are-signaling-cm246390</link>
      <category>Investing</category>
      <category>Stocks</category>
      <title>Oil Pulling Back, Gold Retesting Lows: What 8 Key Charts Are Signaling</title>
      <description>From Japanese bonds to US corporate debt, and from biotechs to oil and gold, here's a roundup of several key charts and what they're indicating about today's markets.    WTI oil is pulling back&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/fuxvGNFmxWw" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 15 May 2013 19:35:00 Z</pubDate>
      <a10:updated>2013-05-15T18:29:14Z</a10:updated>
      <author>Fil Zucchi</author>
      <nasdaq:tickers>IBB</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/oil-pulling-back-gold-retesting-lows-what-8-key-charts-are-signaling-cm246390</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/amgen-inc-amgn-exdividend-date-scheduled-for-may-14-2013-cm245485">
      <guid isPermaLink="false">245485</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/reFOOhXCKA0/amgen-inc-amgn-exdividend-date-scheduled-for-may-14-2013-cm245485</link>
      <category>News Headlines</category>
      <category>Stocks</category>
      <title>Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 14, 2013</title>
      <description>Amgen Inc. (  AMGN  ) will begin trading ex-dividend on May 14, 2013. A cash dividend payment of $0.47 per share is scheduled to be paid on June 07, 2013. Shareholders who purchased AMGN stock&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/reFOOhXCKA0" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 13 May 2013 15:39:06 Z</pubDate>
      <a10:updated>2013-05-13T13:21:43Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>AMGN</nasdaq:tickers>
      <nasdaq:tickers>BIIB</nasdaq:tickers>
      <nasdaq:tickers>FBT</nasdaq:tickers>
      <nasdaq:tickers>GILD</nasdaq:tickers>
      <nasdaq:tickers>IBB</nasdaq:tickers>
      <nasdaq:tickers>PBE</nasdaq:tickers>
      <nasdaq:tickers>PJP</nasdaq:tickers>
      <nasdaq:tickers>XLV</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/amgen-inc-amgn-exdividend-date-scheduled-for-may-14-2013-cm245485</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/best-etfs-in-2013-dbjp-teslafueled-qcln-cm246162">
      <guid isPermaLink="false">246162</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MtbuO-e6BYo/best-etfs-in-2013-dbjp-teslafueled-qcln-cm246162</link>
      <category>Investing</category>
      <category>ETFs</category>
      <title>Best ETFs In 2013: DBJP, Tesla-Fueled QCLN</title>
      <description>The First Trust Nasdaq Clean Edge Green Energy ETF (NasdaqGM:QCLN) is challenging the db X-trackers MSCI Japan Hedged Equity ETF (NYSEArca:DBJP) for first position in a tally of top-performing&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/MtbuO-e6BYo" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 13 May 2013 15:00:00 Z</pubDate>
      <a10:updated>2013-05-15T14:06:51Z</a10:updated>
      <author>Cinthia Murphy</author>
      <nasdaq:tickers>BBH</nasdaq:tickers>
      <nasdaq:tickers>GEX</nasdaq:tickers>
      <nasdaq:tickers>IBB</nasdaq:tickers>
      <nasdaq:tickers>PBE</nasdaq:tickers>
      <nasdaq:tickers>QCLN</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/best-etfs-in-2013-dbjp-teslafueled-qcln-cm246162</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/the-big-picture-charts-look-positive-cm241566">
      <guid isPermaLink="false">241566</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wXWE0HdP0dQ/the-big-picture-charts-look-positive-cm241566</link>
      <category>Investing</category>
      <category>Stocks</category>
      <title>The Big Picture Charts Look Positive</title>
      <description>Good morning and happy Monday. I'm not sure I can add anything earth-shattering to the refrains that "the market needs a pullback," "everyone is expecting a pullback, therefore it&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/wXWE0HdP0dQ" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 29 Apr 2013 17:10:00 Z</pubDate>
      <a10:updated>2013-04-29T15:07:11Z</a10:updated>
      <author>Fil Zucchi</author>
      <nasdaq:tickers>AAPL</nasdaq:tickers>
      <nasdaq:tickers>IBB</nasdaq:tickers>
      <nasdaq:tickers>QQQ</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/the-big-picture-charts-look-positive-cm241566</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/this-dead-money-sector-is-leading-the-sp-this-year-cm230260">
      <guid isPermaLink="false">230260</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jz3V7rZuT_o/this-dead-money-sector-is-leading-the-sp-this-year-cm230260</link>
      <category>Investing</category>
      <category>ETFs</category>
      <category>Investing Ideas</category>
      <title>This Dead Money Sector is Leading the S&amp;P This Year</title>
      <description>"This is where money goes to die," has described one sector over the past decade but this year, things are different.  That industry is health care and for the first time since 1988,&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/jz3V7rZuT_o" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 25 Mar 2013 16:21:17 Z</pubDate>
      <a10:updated>2013-03-26T19:21:12Z</a10:updated>
      <author>Tim Parker</author>
      <nasdaq:tickers>AMGN</nasdaq:tickers>
      <nasdaq:tickers>CELG</nasdaq:tickers>
      <nasdaq:tickers>IBB</nasdaq:tickers>
      <nasdaq:tickers>IHE</nasdaq:tickers>
      <nasdaq:tickers>LLY</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/this-dead-money-sector-is-leading-the-sp-this-year-cm230260</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/gilead-puts-biotech-etfs-in-focus-etf-news-and-commentary-cm225810">
      <guid isPermaLink="false">225810</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VsjBhwR-GMU/gilead-puts-biotech-etfs-in-focus-etf-news-and-commentary-cm225810</link>
      <category>Investing</category>
      <category>ETFs</category>
      <title>Gilead Puts Biotech ETFs in Focus - ETF News And Commentary</title>
      <description>California-based Gilead Sciences (  GILD  ) was in focus last week as it saw some encouraging clinical trial data on its HIV pill-TAF. This report pushed up GILD by about 4.5% last week and&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/VsjBhwR-GMU" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 11 Mar 2013 19:10:39 Z</pubDate>
      <a10:updated>2013-03-11T16:13:43Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>BBH</nasdaq:tickers>
      <nasdaq:tickers>FBT</nasdaq:tickers>
      <nasdaq:tickers>GILD</nasdaq:tickers>
      <nasdaq:tickers>IBB</nasdaq:tickers>
      <nasdaq:tickers>PBE</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/gilead-puts-biotech-etfs-in-focus-etf-news-and-commentary-cm225810</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/perrigo-company-prgo-exdividend-date-scheduled-for-february-27-2013-cm220697">
      <guid isPermaLink="false">220697</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tDds9S0_P7A/perrigo-company-prgo-exdividend-date-scheduled-for-february-27-2013-cm220697</link>
      <category>News Headlines</category>
      <category>Stocks</category>
      <title>Perrigo Company (PRGO) Ex-Dividend Date Scheduled for February 27, 2013</title>
      <description>Perrigo Company (  PRGO  ) will begin trading ex-dividend on February 27, 2013. A cash dividend payment of $0.09 per share is scheduled to be paid on March 19, 2013. Shareholders who purchased&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/tDds9S0_P7A" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 25 Feb 2013 19:00:05 Z</pubDate>
      <a10:updated>2013-02-25T14:26:43Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>IBB</nasdaq:tickers>
      <nasdaq:tickers>IHE</nasdaq:tickers>
      <nasdaq:tickers>JNJ</nasdaq:tickers>
      <nasdaq:tickers>PFE</nasdaq:tickers>
      <nasdaq:tickers>PRGO</nasdaq:tickers>
      <nasdaq:tickers>QQXT</nasdaq:tickers>
      <nasdaq:tickers>XPH</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/perrigo-company-prgo-exdividend-date-scheduled-for-february-27-2013-cm220697</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/are-global-health-care-etfs-worth-prescribing-cm220309">
      <guid isPermaLink="false">220309</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JyoDBnF9Lns/are-global-health-care-etfs-worth-prescribing-cm220309</link>
      <category>Investing</category>
      <category>ETFs</category>
      <category>International</category>
      <category>Investing Ideas</category>
      <title>Are Global Health Care ETFs Worth Prescribing?</title>
      <description>Conservative investors and risk-takers alike have been rewarded for owning U.S. health care stocks and  ETFs  focusing on those names in recent years.  The data supports that assertion. A look&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/JyoDBnF9Lns" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 22 Feb 2013 21:24:34 Z</pubDate>
      <a10:updated>2013-02-23T14:36:39Z</a10:updated>
      <author>ETF Professor</author>
      <nasdaq:tickers>IBB</nasdaq:tickers>
      <nasdaq:tickers>IRY</nasdaq:tickers>
      <nasdaq:tickers>IXJ</nasdaq:tickers>
      <nasdaq:tickers>TEVA</nasdaq:tickers>
      <nasdaq:tickers>XLV</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/are-global-health-care-etfs-worth-prescribing-cm220309</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/2-etfs-to-buy-now-cm218233">
      <guid isPermaLink="false">218233</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fT5_RA241E4/2-etfs-to-buy-now-cm218233</link>
      <category>Investing</category>
      <category>ETFs</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <title>2 ETFs to Buy Now</title>
      <description>What do you do when the market is so overbought that you can’t bring yourself to buy anything, but not so overbought that you feel comfortable running out and shorting everything?  What I do&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/fT5_RA241E4" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 15 Feb 2013 21:32:37 Z</pubDate>
      <a10:updated>2013-02-15T16:32:40Z</a10:updated>
      <author>Teeka Tiwari</author>
      <nasdaq:tickers>IBB</nasdaq:tickers>
      <nasdaq:tickers>PJP</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/2-etfs-to-buy-now-cm218233</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/amgen-inc-amgn-exdividend-date-scheduled-for-february-11-2013-cm215021">
      <guid isPermaLink="false">215021</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CcNRkw17oVg/amgen-inc-amgn-exdividend-date-scheduled-for-february-11-2013-cm215021</link>
      <category>News Headlines</category>
      <category>Stocks</category>
      <title>Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 11, 2013</title>
      <description>Amgen Inc. (  AMGN  ) will begin trading ex-dividend on February 11, 2013. A cash dividend payment of $0.47 per share is scheduled to be paid on March 07, 2013. Shareholders who purchased AMGN&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/CcNRkw17oVg" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 07 Feb 2013 19:00:04 Z</pubDate>
      <a10:updated>2013-02-07T14:25:44Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>AMGN</nasdaq:tickers>
      <nasdaq:tickers>BIIB</nasdaq:tickers>
      <nasdaq:tickers>GILD</nasdaq:tickers>
      <nasdaq:tickers>IBB</nasdaq:tickers>
      <nasdaq:tickers>IYH</nasdaq:tickers>
      <nasdaq:tickers>PBE</nasdaq:tickers>
      <nasdaq:tickers>PJP</nasdaq:tickers>
      <nasdaq:tickers>XLV</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/amgen-inc-amgn-exdividend-date-scheduled-for-february-11-2013-cm215021</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/safest-way-to-play-biotech-cooks-kitchen-cm211041">
      <guid isPermaLink="false">211041</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oCJeA7Ro-dA/safest-way-to-play-biotech-cooks-kitchen-cm211041</link>
      <category>Investing</category>
      <category>Stocks</category>
      <title>Safest Way to Play Biotech - Cook`s Kitchen</title>
      <description>Investing in biotechnology can be exciting, profitable, and loaded with land mines. For every company that hits the jackpot with a new marketable drug that makes it through the FDA gauntlets,&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/oCJeA7Ro-dA" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 25 Jan 2013 13:54:01 Z</pubDate>
      <a10:updated>2013-01-25T23:23:35Z</a10:updated>
      <author>Kevin Cook</author>
      <nasdaq:tickers>AMGN</nasdaq:tickers>
      <nasdaq:tickers>CELG</nasdaq:tickers>
      <nasdaq:tickers>GILD</nasdaq:tickers>
      <nasdaq:tickers>IBB</nasdaq:tickers>
      <nasdaq:tickers>VRTX</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/safest-way-to-play-biotech-cooks-kitchen-cm211041</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/perrigo-company-prgo-exdividend-date-scheduled-for-november-27-2012-cm192395">
      <guid isPermaLink="false">192395</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5d1VILb34Is/perrigo-company-prgo-exdividend-date-scheduled-for-november-27-2012-cm192395</link>
      <category>News Headlines</category>
      <category>Stocks</category>
      <title>Perrigo Company (PRGO) Ex-Dividend Date Scheduled for November 27, 2012</title>
      <description>Perrigo Company (  PRGO  ) has announced an ex-dividend date of November 27, 2012 and a cash dividend payment of $0.09 per share scheduled for December 17, 2012. Shareholders who purchased PRGO&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/5d1VILb34Is" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 23 Nov 2012 19:00:03 Z</pubDate>
      <a10:updated>2012-11-23T14:25:20Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>ETF</nasdaq:tickers>
      <nasdaq:tickers>IBB</nasdaq:tickers>
      <nasdaq:tickers>IHE</nasdaq:tickers>
      <nasdaq:tickers>JNJ</nasdaq:tickers>
      <nasdaq:tickers>PFE</nasdaq:tickers>
      <nasdaq:tickers>PRGO</nasdaq:tickers>
      <nasdaq:tickers>XPH</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/perrigo-company-prgo-exdividend-date-scheduled-for-november-27-2012-cm192395</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/biotech-etfs-a-fiscal-cliff-safe-haven-etf-news-and-commentary-cm190777">
      <guid isPermaLink="false">190777</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9WOySHlfNGw/biotech-etfs-a-fiscal-cliff-safe-haven-etf-news-and-commentary-cm190777</link>
      <category>Investing</category>
      <category>ETFs</category>
      <title>Biotech ETFs: A Fiscal Cliff Safe Haven? - ETF News And Commentary</title>
      <description>With the election over, many investors assumed that one of the key risk events for U.S. markets was past us. However, this certainly hasn't been the case, as the election worries were just&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/9WOySHlfNGw" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 16 Nov 2012 20:35:01 Z</pubDate>
      <a10:updated>2012-11-16T17:40:28Z</a10:updated>
      <author>Eric Dutram</author>
      <nasdaq:tickers>AMGN</nasdaq:tickers>
      <nasdaq:tickers>BBH</nasdaq:tickers>
      <nasdaq:tickers>FBT</nasdaq:tickers>
      <nasdaq:tickers>GILD</nasdaq:tickers>
      <nasdaq:tickers>IBB</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/biotech-etfs-a-fiscal-cliff-safe-haven-etf-news-and-commentary-cm190777</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/gilead-sciences-and-celgene-liven-up-biotech-etfs-cm189255">
      <guid isPermaLink="false">189255</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EBL4oPb23Dg/gilead-sciences-and-celgene-liven-up-biotech-etfs-cm189255</link>
      <category>Investing</category>
      <category>ETFs</category>
      <title>Gilead Sciences And Celgene Liven Up Biotech ETFs</title>
      <description>Positive clinical trial results fromGilead Sciences (  GILD  ) andCelgene (  CELG  ) released over the weekend lifted biotechnology  ETFs  to their biggest one-day gains in as many as three&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/EBL4oPb23Dg" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 13 Nov 2012 04:49:00 Z</pubDate>
      <a10:updated>2012-11-13T02:23:07Z</a10:updated>
      <author>Investor's Business Daily</author>
      <nasdaq:tickers>BBH</nasdaq:tickers>
      <nasdaq:tickers>CELG</nasdaq:tickers>
      <nasdaq:tickers>GILD</nasdaq:tickers>
      <nasdaq:tickers>IBB</nasdaq:tickers>
      <nasdaq:tickers>SPY</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/gilead-sciences-and-celgene-liven-up-biotech-etfs-cm189255</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/major-etfs-erase-morning-losses-on-bernanke-letter-cm167048">
      <guid isPermaLink="false">167048</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2a7dduYILOs/major-etfs-erase-morning-losses-on-bernanke-letter-cm167048</link>
      <category>Investing</category>
      <category>ETFs</category>
      <title>Major ETFs Erase Morning Losses On Bernanke Letter</title>
      <description>Major ETFs rebounded from morning weakness to post gains by midday Friday on news that the European Central Bank is considering setting interest-rate limits on a new-bond buying program in&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/2a7dduYILOs" height="1" width="1"/&gt;</description>
      <pubDate>Sat, 25 Aug 2012 02:12:00 Z</pubDate>
      <a10:updated>2012-08-24T23:32:22Z</a10:updated>
      <author>Investor's Business Daily</author>
      <nasdaq:tickers>DIA</nasdaq:tickers>
      <nasdaq:tickers>IBB</nasdaq:tickers>
      <nasdaq:tickers>ITB</nasdaq:tickers>
      <nasdaq:tickers>QQQ</nasdaq:tickers>
      <nasdaq:tickers>SPY</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/major-etfs-erase-morning-losses-on-bernanke-letter-cm167048</feedburner:origLink></item>
  </channel>
</rss>
